Approximately 20%-30% of individuals with MASLD progress to MASH, characterized by hepatocyte ballooning, lobular inflammation, and variable fibrosis, and 10%-20% of MASH patients develop advanced fibrosis (stages F3-F4) or cirrhosis over their lifetime [6,13]
Finally, this is likely to be a mechanism used by many other receptors in other tissues, so that the implication of understanding how these signalling hubs work is far reaching for many human disorders beyond diabetes. Article text (excluding photos or graphics) Imperial College London
The appetite suppression effect often begins within the first week or two, though significant weight loss typically becomes noticeable around weeks 4 to 8
The pharmacokinetic profiles of these formulations indicate that maximum plasma concentrations are typically attained within 1 to 3 days following SC administration, while steady-state plasma levels are generally achieved after 4 to 5 weeks of once-weekly dosing
Bacterial pathogens can both trigger NETs formation and employ diverse strategies to evade or degrade these structures
Well explore what science tells us so far, whats still unclear, and why these drugs may ultimately be a double-edged sword for brain health
